Stocktoria

Nuwellis, Inc. NUWE

Nasdaq · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2012-02-16 · LEI

Nuwellis, Inc. financials (annual)

Revenue
$1.3M $3.6M $5.0M $5.5M $7.4M $7.9M $8.5M $8.9M $8.7M $8.3M 2016201720182019202020212022202320242025
Net income
-$15.8M -$13.4M -$17.0M -$18.1M -$15.8M -$19.6M -$14.5M -$20.2M -$11.2M -$17.5M 2016201720182019202020212022202320242025
Free cash flow
-$16.4M -$12.2M -$14.8M -$16.9M -$16.9M -$18.1M -$15.3M -$18.1M -$9.7M -$10.9M 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$8.3M$8.7M$8.9M$8.5M$7.9M$7.4M$5.5M$5.0M$3.6M$1.3M
Gross profit$5.1M$5.7M$5.0M$4.8M$4.5M$4.1M
R&D expense$2.7M$3.2M$5.4M$4.3M$5.0M$3.7M$4.7M$3.1M$1.5M$8.1M
SG&A expense$13.5M$13.5M$17.2M$17.6M$19.0M$17.4M$16.3M$15.3M$10.2M$8.1M
Operating income-$11.1M-$11.0M-$17.6M-$17.2M-$19.5M-$17.0M-$18.1M-$17.0M-$14.8M-$15.7M
Interest expense$504,000
Income tax$5,000$5,000$8,000$9,000$9,000$9,000$8,000$6,000$6,000-$54,000
Net income-$17.5M-$11.2M-$20.2M-$14.5M-$19.6M-$15.8M-$18.1M-$17.0M-$13.4M-$15.8M
EPS (diluted)$-25.39$-353.30$-360.06$-83.55$-285.36$-10.67
Operating cash flow-$10.8M-$9.6M-$17.9M-$15.1M-$17.8M-$16.6M-$16.4M-$14.6M-$11.9M-$16.3M
Free cash flow-$10.9M-$9.7M-$18.1M-$15.3M-$18.1M-$16.9M-$16.9M-$14.8M-$12.2M-$16.4M
Cash & equivalents$1.1M$5.1M$3.8M$17.7M$8.7M$14.4M$1.3M$5.5M$15.6M$1.3M
Inventory$1.9M$1.7M$2.0M$2.7M$2.8M$3.0M$1.8M$1.7M$1.6M$677,000
Total assets$6.1M$9.9M$9.8M$24.7M$30.4M$20.0M$5.6M$8.8M$18.5M$7.5M
Total liabilities$3.5M$3.3M$6.6M$12.3M$4.5M$3.7M$3.6M$2.8M$2.2M$5.2M
Shareholders' equity$2.6M$6.5M$3.0M$12.4M$25.9M$16.3M$2.0M$5.9M$16.2M$1.8M

Growth · year-over-year · Revenue CAGR 22.9%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth-5.4%-1.4%+3.8%+7.9%+6.5%+35.0%+10.3%+40.7%+175.6%+2084.7%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.